Sildec Plus Gel Dosage

• Dosage of Sildec Plus Gel in details
• Sildec Plus Gel interactions
• Sildec Plus Gel reviews

Dosage of Sildec Plus Gel in details

Carefully consider the potential benefits and risks of Sildec Plus Gel extended-release tablets, and other treatment options before deciding to use Sildec Plus Gel extended-release tablets. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals.

After observing the response to initial therapy with Sildec Plus Gel extended-release tablets the dose and frequency should be adjusted to suit an individual patient’s needs.

For the relief of osteoarthritis, the recommended dosage is 100 mg daily.

For the relief of rheumatoid arthritis, the recommended dosage is 100 mg daily. In the rare patient where Sildec Plus Gel extended-release tablets 100 mg/day is unsatisfactory, the dose may be increased to 100 mg twice a day if the benefits outweigh the clinical risks of increased side effects.

Different formulations of Sildec Plus Gel (Sildec Plus Gel enteric-coated tablets; Sildec Plus Gel extended-release tablets; Sildec Plus Gel potassium immediate-release tablets) are not necessarily bioequivalent even if the milligram strength is the same.

What other drugs will affect Sildec Plus Gel?

Ask your doctor before using Sildec Plus Gel if you take an antidepressant such as citalopram, escitalopram, fluoxetine (Prozac), fluvoxamine, paroxetine, sertraline (Zoloft), trazodone, or vilazodone. Taking any of these medicines with an NSAID may cause you to bruise or bleed easily.

Tell your doctor about all your current medicines and any you start or stop using, especially:

• cyclosporine;

• lithium;

• methotrexate;

• rifampin;

• antifungal medicine;

• a blood thinner (warfarin, Coumadin, Jantoven);

• heart or blood pressure medication, including a diuretic or "water pill";

• other forms of Sildec Plus Gel (Flector, Pennsaid, Solaraze, Voltaren Gel);

• other NSAIDs - aspirin, ibuprofen (Advil, Motrin), naproxen (Aleve), celecoxib (Celebrex), indomethacin, meloxicam, and others; or

• steroid medicine (prednisone and others).

This list is not complete. Other drugs may interact with Sildec Plus Gel, including prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible interactions are listed in this medication guide.

Sildec Plus Gel interactions

Aspirin: Concomitant administration of Sildec Plus Gel and aspirin is not recommended because Sildec Plus Gel is displaced from its binding sites during the concomitant administration of aspirin, resulting in lower plasma concentrations, peak plasma levels, and AUC values.

Anticoagulants: While studies have not shown Sildec Plus Gel to interact with anticoagulants of the warfarin type, caution should be exercised, nonetheless, since interactions have been seen with other NSAIDs. Because prostaglandins play an important role in hemostasis, and NSAIDs affect platelet function as well, concurrent therapy with all NSAIDs, including Sildec Plus Gel, and warfarin requires close monitoring of patients to be certain that no change in their anticoagulant dosage is required.

Digoxin, Methotrexate, Cyclosporine: Sildec Plus Gel, like other NSAIDs, may affect renal prostaglandins and increase the toxicity of certain drugs. Ingestion of Sildec Plus Gel may increase serum concentrations of digoxin and methotrexate and increase cyclosporineís nephrotoxicity. Patients who begin taking Sildec Plus Gel or who increase their Sildec Plus Gel dose or any other NSAID while taking digoxin, methotrexate, or cyclosporine may develop toxicity characteristics for these drugs. They should be observed closely, particularly if renal function is impaired. In the case of digoxin, serum levels should be monitored.

Lithium: Sildec Plus Gel decreases lithium renal clearance and increases lithium plasma levels. In patients taking Sildec Plus Gel and lithium concomitantly, lithium toxicity may develop.

Oral Hypoglycemics:

Sildec Plus Gel does not alter glucose metabolism in normal subjects nor does it alter the effects of oral hypoglycemic agents. There are rare reports, however, from marketing experiences, of changes in effects of insulin or oral hypoglycemic agents in the presence of Sildec Plus Gel that necessitated changes in the doses of such agents. Both hypo- and hyperglycemic effects have been reported. A direct causal relationship has not been established, but physicians should consider the possibility that Sildec Plus Gel may alter a diabetic patientís response to insulin or oral hypoglycemic agents.

Diuretics: Sildec Plus Gel and other NSAIDs can inhibit the activity of diuretics. Concomitant treatment with potassium-sparing diuretics may be associated with increased serum potassium levels.

Other Drugs: In small groups of patients (7-10/interaction study), the concomitant administration of azathioprine, gold, chloroquine, D-penicillamine, prednisolone, doxycycline, or digitoxin did not significantly affect the peak levels and AUC values of Sildec Plus Gel. Phenobarbital toxicity has been reported to have occurred in a patient on chronic phenobarbital treatment following the initiation of Sildec Plus Gel therapy.

Protein Binding

In vitro, Sildec Plus Gel interferes minimally or not at all with the protein binding of salicylic acid (20% decrease in binding), tolbutamide, prednisolone (10% decrease in binding), or warfarin. Benzylpenicillin, ampicillin, oxacillin, chlortetracycline, doxycycline, cephalothin, erythromycin, and sulfamethoxazole have no influence in vitro on the protein binding of Sildec Plus Gel in human serum.

Drug/Laboratory Test Interactions

Effect on Blood Coagulation: Sildec Plus Gel increases platelet aggregation time but does not affect bleeding time, plasma thrombin clotting time, plasma fibrinogen, or factors V and VII to XII. Statistically significant changes in prothrombin and partial thromboplastin times have been reported in normal volunteers. The mean changes were observed to be less than 1 second in both instances, however, and are unlikely to be clinically important. Sildec Plus Gel is a prostaglandin synthetase inhibitor, however, and all drugs that inhibit prostaglandin synthesis interfere with platelet function to some degree; therefore, patients who may be adversely affected by such an action should be carefully observed.

References

1. DailyMed. "DICLOFENAC EPOLAMINE: DailyMed provides trustworthy information about marketed drugs in the United States. DailyMed is the official provider of FDA label information (package inserts).". https://dailymed.nlm.nih.gov/dailyme... (accessed September 17, 2018).
2. FDA/SPL Indexing Data. "144O8QL0L1: The UNique Ingredient Identifier (UNII) is an alphanumeric substance identifier from the joint FDA/USP Substance Registration System (SRS).". https://www.fda.gov/ForIndustry/Data... (accessed September 17, 2018).
3. MeSH. "Cyclooxygenase Inhibitors". https://www.ncbi.nlm.nih.gov/mesh/68... (accessed September 17, 2018).

Reviews

The results of a survey conducted on ndrugs.com for Sildec Plus Gel are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Sildec Plus Gel. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.

User reports

Consumer reviews

There are no reviews yet. Be the first to write one!

Your name:  Email:  Spam protection:  < Type 13 here

Information checked by Dr. Sachin Kumar, MD Pharmacology